Geron (GERN) Cash & Equivalents (2010 - 2026)

Geron has reported Cash & Equivalents for 17 years, with the latest figure at $48.7 million in Q1 2026.

• Quarterly Cash & Equivalents rose 2512.44% year-over-year to $48.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.7 million (up 2512.44% YoY) and the FY2025 annual result came in at $53.9 million, up 2799.41% from the prior year.
• Cash & Equivalents eased to $48.7 million in Q1 2026 per GERN's latest filing, from $53.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $189.8 million in Q1 2024 and troughed at $364000.0 in Q3 2022.
• A 5-year average of $48.1 million and a median of $48.7 million in 2026 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents soared 51889.32% in 2024, then plunged 99.02% in 2025.
• Over 5 years, Cash & Equivalents stood at $56.8 million in 2022, then gained by 23.18% to $70.0 million in 2023, then plunged by 97.34% to $1.9 million in 2024, then surged by 2799.41% to $53.9 million in 2025, then declined by 9.66% to $48.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $48.7 million, $53.9 million, and $78.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.